Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review
- PMID: 34002501
- PMCID: PMC8129843
- DOI: 10.1002/wps.20881
Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review
Abstract
Top-tier evidence on the safety/tolerability of 80 medications in children/adolescents with mental disorders has recently been reviewed in this jour-nal. To guide clinical practice, such data must be combined with evidence on efficacy and acceptability. Besides medications, psychosocial inter-ventions and brain stimulation techniques are treatment options for children/adolescents with mental disorders. For this umbrella review, we systematically searched network meta-analyses (NMAs) and meta-analyses (MAs) of randomized controlled trials (RCTs) evaluating 48 medications, 20 psychosocial interventions, and four brain stimulation techniques in children/adolescents with 52 different mental disorders or groups of mental disorders, reporting on 20 different efficacy/acceptability outcomes. Co-primary outcomes were disease-specific symptom reduction and all-cause discontinuation ("acceptability"). We included 14 NMAs and 90 MAs, reporting on 15 mental disorders or groups of mental disorders. Overall, 21 medications outperformed placebo regarding the co-primary outcomes, and three psychosocial interventions did so (while seven outperformed waiting list/no treatment). Based on the meta-analytic evidence, the most convincing efficacy profile emerged for amphetamines, methylphenidate and, to a smaller extent, behavioral therapy in attention-deficit/hyperactivity disorder; aripiprazole, risperidone and several psychosocial interventions in autism; risperidone and behavioral interventions in disruptive behavior disorders; several antipsychotics in schizophrenia spectrum disorders; fluoxetine, the combination of fluoxetine and cognitive behavioral therapy (CBT), and interpersonal therapy in depression; aripiprazole in mania; fluoxetine and group CBT in anxiety disorders; fluoxetine/selective serotonin reuptake inhibitors, CBT, and behavioral therapy with exposure and response prevention in obsessive-compulsive disorder; CBT in post-traumatic stress disorder; imipramine and alarm behavioral intervention in enuresis; behavioral therapy in encopresis; and family therapy in anorexia nervosa. Results from this umbrella review of interventions for mental disorders in children/adolescents provide evidence-based information for clinical decision making.
Keywords: ADHD; Children; acceptability; adolescents; autism; brain stimulation; disruptive behavior disorders; efficacy; pharmacotherapy; psychosocial interventions; psychotherapies.
© 2021 World Psychiatric Association.
Figures
Similar articles
-
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.Lancet Psychiatry. 2020 Jul;7(7):581-601. doi: 10.1016/S2215-0366(20)30137-1. Lancet Psychiatry. 2020. PMID: 32563306 Free PMC article.
-
Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis.Lancet Child Adolesc Health. 2023 Feb;7(2):112-126. doi: 10.1016/S2352-4642(22)00316-9. Epub 2022 Dec 14. Lancet Child Adolesc Health. 2023. PMID: 36528030
-
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.World Psychiatry. 2020 Jun;19(2):214-232. doi: 10.1002/wps.20765. World Psychiatry. 2020. PMID: 32394557 Free PMC article.
-
A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.Health Technol Assess. 2016 Jun;20(43):1-392. doi: 10.3310/hta20430. Health Technol Assess. 2016. PMID: 27306503 Free PMC article. Review.
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Aug 09;8:CD008559. doi: 10.1002/14651858.CD008559.pub3. PMID: 22972123 Updated. Review.
Cited by
-
Convergence mechanism of mindfulness intervention in treating attention deficit hyperactivity disorder: Clues from current evidence.World J Clin Cases. 2022 Sep 16;10(26):9219-9227. doi: 10.12998/wjcc.v10.i26.9219. World J Clin Cases. 2022. PMID: 36159418 Free PMC article. Review.
-
Surface electroencephalographic neurofeedback improves sustained attention in ADHD: a meta-analysis of randomized controlled trials.Child Adolesc Psychiatry Ment Health. 2022 Dec 19;16(1):104. doi: 10.1186/s13034-022-00543-1. Child Adolesc Psychiatry Ment Health. 2022. PMID: 36536438 Free PMC article.
-
Major depressive disorder.Nat Rev Dis Primers. 2023 Aug 24;9(1):44. doi: 10.1038/s41572-023-00454-1. Nat Rev Dis Primers. 2023. PMID: 37620370 Review.
-
Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment.Transl Psychiatry. 2024 Mar 30;14(1):171. doi: 10.1038/s41398-024-02866-3. Transl Psychiatry. 2024. PMID: 38555309 Free PMC article.
-
Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.Br J Psychiatry. 2023 Jul;223(1):282-294. doi: 10.1192/bjp.2022.203. Br J Psychiatry. 2023. PMID: 37194556 Free PMC article. Review.
References
-
- Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age‐of‐onset distributions of DSM‐IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593‐602. - PubMed
-
- Wang PS, Berglund P, Olfson M et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:603‐13. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources